(Voiceover) Tattoos are everywhere you look… in fact, over 70 million Americans have at least one tattoo and independent research shows that over half are considering a tattoo removal.
That’s why according to Market Research Future, the global market for tattoo removal is projected to be $4.8B by 2023.
(POV Wally) Hi, my name is Wally Klemp and I’m the executive chairman of Soliton Inc. and we believe we have the potential to become a dominant player in this multibillion dollar tattoo removal market because of our patented and virtually painless acoustic shockwave technology.
We’ve also recently discovered that our device may have the potential to reduce cellulite and blast apart fat cells, which we will explain later in this video.
We’ve spent 25 million dollars over the past 5 years developing our breakthrough technology that, in clinical trials, appears to dramatically accelerate the removal of tattoos by doing something that has never been done before in this industry.
We call this technology Rapid Acoustic Pulse or RAP, and it uses highly tuned acoustic shockwaves with enough power to literally blast apart the cellular structures that hold tattoo ink in place and to reach ink particles that today’s lasers just can’t get to on their own.
So, how much does the Soliton RAP actually improve tattoo removal?
Well on average, using the current standard of care lasers, it will take 10 or more painful treatments over a 1 to 2-year period to completely remove a typical tattoo.
Now, imagine how much better this would be if we could remove a tattoo in just 2 to 3 office visits over a 3 to 4-month period instead of 1 to 2 years.
Wouldn’t most people choose that option instead?
Of course, they would! And, that’s exactly what clinical trials of our patented shockwave technology have shown, and it’s why we believe that by removing tattoos 3 to 4 times faster than current methods, Soliton could become the new standard of care in this multibillion dollar industry.
Making this possible required new science and new technology. Our device is covered by 8 patent families, representing 38 issued or pending patents worldwide. And, that’s why it took us the last 5 years and $25 million to accomplish.
To see Soliton RAP in action and to learn more about how our device works, I encourage you to watch the more detailed videos below.
We believe our breakthrough RAP technology will change tattoo removal forever, but we also believe RAP may be able to target and treat additional indications that could dwarf the size of the tattoo removal market.
Just recently, we discovered in preclinical testing that our patented shockwave technology may have the potential to blast apart fat cells, which could make today’s most popular fat reduction technologies more effective.
This new discovery caught the attention of a multibillion dollar, global aesthetics company and since then, we have begun a collaboration trial with them using Soliton RAP to potentially accelerate their own fat reduction technology.
If Soliton RAP has the expected effect, this could form the basis for an important strategic relationship.
What we’ve also learned in our animal studies, is that our shockwave technology creates mechanical stress at the cellular level that induces significant collagen growth.
So, why is collagen growth important?
Well, increased collagen production strengthens and adds structure to the skin and therefore it has the potential to reverse or eliminate skin laxity and the appearance of cellulite.
And, cellulite reduction is, yet, another multibillion dollar market opportunity.
Soliton’s RAP technology was licensed from The University of Texas MD Anderson Cancer Center, one of the leading research centers in the world and they remain a shareholder of our Company today.
Our executive and science advisory teams, as well as our board of directors are comprised of aesthetic and medical device experts, including senior management from the makers of CoolSculpt, the fat reduction technology recently acquired by Allergan for $2.4 billion.
Over the next year and a half, our goal is to launch Soliton RAP into the tattoo removal market and position it as the new standard of care. And, if we are right about the potential to accelerate fat removal and/or the ability to reduce cellulite, we believe Soliton could become a significant acquisition target for a number of Fortune 500 companies.
All of this activity also creates an important opportunity for investors because we have decided to give all those who understand Soliton’s potential the opportunity to participate in our Nasdaq IPO, giving you the opportunity to invest and own a piece of our breakthrough shockwave technology.
However, we are limiting our offering size to a set amount and once we achieve the preset maximum, the offering will be closed, and we will no longer be able to accept IPO investments from investors like you.
So, if this looks like an opportunity you’d like to consider, please follow the instructions on this page to reserve your spot as a shareholder of Soliton.
We appreciate your taking the time to research our company and we look forward to having you join us on this exciting journey!
VIDEO WITH TEXT FOR HOMEPAGE
As you can imagine removing tattoos is big business
The industry is expected to grow to $4.8B by 2023
In just the United States alone
More than 44 million people desire some form of tattoo removal
Over the next 3-5 years, we believe we can become the dominant player
Because of our clinically proven rapid acoustic pulse (RAP) device
Today, with current standard of care lasers
An average removal will take 10-12 painful sessions over a 1-2 year period
What if our device could remove a tattoo in 2-3 sessions vs 10-12 sessions?
How many tattoo owners would choose the Soliton method instead?
We think most will and that’s why we believe that over the next 3-5 years
We can become the dominant player in this $4.8B industry
We’ve also found that our breakthrough shockwave device
Has the potential to accelerate fat and cellulite removal
This discovery caught the attention of a global aesthetics company
We are now currently in a collaboration trial with them using our device
To potentially accelerate their own fat reduction technology
We believe that we’ve barely scratched the surface
Of what our patented RAP technology can do
We’re currently evaluating the following indications for future development…
Cancer Therapy: Destruction of Tumors
Sports Medicine: Plantar Fasciitis & Calcific Tendinitis
Interventional Radiology: Peripheral Artery Disease
Orthopedic: Bone Healing
Game changing science with market-building potential.
We are Soliton!
Sign up on our site to follow our story and watch us grow!
Razor and Blade Script
It takes a tremendous amount of energy for Soliton’s RAP device to generate its acoustic shockwaves. That energy, in the range of 3,000 volts at 3,000 amps, creates an arc between two electrodes within the RAP treatment head, and it does this 100 times per second. Even though these electrodes are made of tungsten, one of the hardest metals known, they can only last so long before they must be replaced. This is why we have designed the RAP treatment head with an easily replaceable cartridge. Each cartridge will last long enough for one typical treatment session with a patient, creating an important “razor and blade” business model that will provide Soliton with a valuable recurring revenue stream.
While it required a tremendous amount of engineering to be able to easily change cartridges in such a high-energy device, the value of potentially being able to remove a tattoo in just 1/3 the time of current methods was well worth it. And, it also means that Soliton will directly benefit from each new patient attracted to the RAP method. Until now, the major players in the tattoo removal space have been limited to one-time laser sales to each clinician, and other than ongoing maintenance, they have had no way to directly benefit from the growth of that clinician’s tattoo removal business. Soliton effectively converts tattoo removal into a recurring revenue stream such that we will be aligned with the clinician to help them grow the market, and we will both benefit from that growth.
Given how much faster tattoos have been shown in clinical trials to be removed with our method, the potential exists for the clinician’s profit to be higher while the cost to the patient for a tattoo removal ends up being the same or even lower. Importantly, because the rate of progress is faster and more predictable, there should be much higher patient satisfaction and a much lower drop-out rate. Everyone wins in this scenario and Soliton’s growth isn’t limited to just how many more clinicians convert to our method.
Cellulite is a complex condition that occurs in nearly 80% of all women because of the uniqueness of their skin’s structure. Women’s skin is more flexible than men’s probably owing to the need for women to accommodate childbirth. However, as this flexible structure weakens with age, subcutaneous fat can begin to push up through openings in the structure, creating the lumpiness associated with cellulite. A critical component of the structure needed to prevent this is collagen, which is produced by fibroblasts in the dermis.
We have discovered in preclinical testing that Soliton’s RAP is capable of inducing fibroblasts to increase their production of collagen and we believe the RAP could become the first non-invasive, virtually painless method for reducing cellulite.
What you see here is a side-by-side comparison of skin, the biopsy on the left is from an untreated area and the one on the right has been treated given just one 2-minute treatment of Soliton RAP. The samples are both prepared with a stain that turns purple when in contact with old collagen and blue when in contact with new collagen. You can see from this comparison that the sample treated with Soliton RAP is filled with new collagen.
Returning to the cellulite skin model, you can see the expected effect as the return of greater collagen structure re-plumps the skin, adds structure and promotes more even skin surface, removing the appearance of cellulite. We are planning to conduct clinical trials in humans in the near future to provide a proof of concept for this multi-billion dollar indication.
Subcutaneous Fat Script
The market for reducing subcutaneous fat is considered an enormous opportunity, as evidenced by Allergan’s recent acquisition of CoolSculpt for $2.4 billion. Based on preclinical testing, we believe Soliton’s RAP has the potential to accelerate the leading technologies and improve their efficacy. And, based on this preclinical data, a multi-billion dollar global aesthetics company has asked us to test the combination of our technology with theirs. If Soliton’s RAP is found to have the anticipated effect, this could result in a company-changing event for our shareholders.
Part of what makes Soliton RAP work is something called “viscoelasticity.” Cellular structures, including fat cells, are said to be viscoelastic because if they are impacted by, say, an acoustic shockwave, they will typically deform slightly and then return back to their original “relaxed” state. This is how a typical cell behaves when it is “elastic” and the rate at which cells return to normal is called the “relaxation rate” and this is a known quantity in biomechanics. So, if you hit the same cell over and over at a rate much faster than its relaxation rate, the cell begins to stiffen and become more viscos. When that happens, the cell is then much more vulnerable and with sufficient energy, we can create irreparable damage to that targeted cell.
Current technologies for subcutaneous fat reduction have gained strong market acceptance, but they typically only achieve 20 to 30% reduction. If Soliton RAP can be shown to significantly increase that level of efficacy, it would represent a major breakthrough for the fat reduction market.